Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program

The Breast · Elsevier

Аннотация

Publication date: December 2026 Source: The Breast, Volume 90 Author(s): A. de Nonneville, J.S. Frenel, D. Loirat, S. Becourt, N. Bénard, M.A. Benderra, M. Campone, F. Dalenc, O. Derbel, I. Desmoulins, A. Deleuze, G. Emile, A. Gonçalves, J. Grenier, W. Jacot, C. Liautard, L. Mansi, M.A. Mouret Reynier, C. Perkins, B. Pistilli

Читать у издателя →

Похожие статьи